1. Division of Gastroenterology, Inflammatory Bowel Disease Center and Humanities Medical School, Milan, Italy;
2. Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, Texas;
3. Pfizer Inc., New York, New York; and
4. Pfizer Inc., Cambridge, Massachusetts